Heart Test Laboratories Inc.
HSCS
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.83M
Close$
$-2.03
183.3% downside
Current Fair Value
183.3% downsideOvervalued by 183.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.83 Million |
|---|---|
| Enterprise Value | $476.14 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.79 |
| Outstanding Shares | 3,162,257 |
Return
| Return on Equity | -77727.33% |
|---|---|
| Return on Assets | -27.29% |
| Return on Invested Capital | -24.90% |
Valuation & Multiples
| P/E Ratio | -0.67 |
|---|---|
| PEG | 0.67 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 249.71 |
| Enterprise Value to EBIT | -0.25 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 8.12 |
| Debt to Equity | 1458.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$50,000
Average shareholder expectationNext Earnings Call
Expected Date
September 10, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data